National Rehabilitation Hospital
Washington D.C., District of Columbia, 20010, United States
NCT Number: NCT00499278
1. What are the characteristics of joint replacement patients (DRGs 209 & 210) served in IRFs and SNFs? How are they similar or different? 2. How are the interventions and processes of care for joint replacement patients different in IRFs and SNFs? 3. What specific interventions or combinations of interventions in IRFs and SNFs make the biggest difference in outcomes for joint replacement patients taking into account patient differences? 4. Which joint replacement patients do better in an IRF and which do better in a SNF? 5. What is the relative cost-effectiveness of IRF and SNF care for joint replacement patients? 6. Are comorbidities among joint replacement patients an adequate indicator of additional medical need during the rehabilitation process? Can a severity-of-illness measure serve as a better indicator of medical need? Are patients with greater medical needs served better in an IRF or a SNF? 7. Can we design a more efficient course of rehabilitation interventions for joint replacement patients in IRFs and SNFs to reduce the length of stay and costs?
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
Washington D.C., District of Columbia, 20010, United States
We need to know if there are systematic differences among joint replacement patients served in both settings and take these into account when evaluating outcomes and cost effectiveness as outlined below. See also Question 6.
How can we best characterize the differences in the care received in an IRF vs. a SNF? What makes the care in an IRF and a SNF different? What do they do similarly and what do they do differently? Consider all interventions, e.g., nursing services, physician interventions, physical and occupational therapies, nutritional support, medications, passive motion exercises, weight-bearing exercises. Also consider timing, intensity, frequency, and duration of therapies.
The relevant outcomes for this study include: (1) the onset of complications during the course of treatment, (2) change in severity of illness from admission to discharge, (3) discharge destination (including unscheduled discharges to acute care), and (4) change in functional status from admission to discharge. We will consider (5) rehospitalizations or readmissions in the first 3-6 months following discharge from post-acute care.
How can we best characterize the differences between patients who do better in one setting or the other? How can these characterizations assist in developing post-acute placement criteria and in characterizing the patient mix that should be used in defining an IRF pursuant to the 75% rule?
For which patients is it more cost-effective to be placed in an IRF and which patients in a SNF taking into account outcomes both at discharge and rehospitalizations during the first 3-6 months following discharge?
Do comorbidities or a severity of illness indicator have better predictive validity in terms of service utilization, costs, and outcomes?
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
To be included in the study's database, the above enrollment criteria need to be met. In addition, patients also must:
Exclusion criteria
MedStar National Rehabilitation Network
Other
Joint Replacement Outcome in Inpatient Rehabilitation Facilities and Nursing Treatment Sites
Acronym: JOINTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108496
Arthritis, Joint Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT07720024
Arthritis, Blount disease
Pathum Thani, Changwat Pathum Thani, Thailand
View Trial DetailsNCT01818401
Arthritis, Joint Diseases
Nantes, France
View Trial DetailsNCT07710404
Arthritis, Joint Diseases
Faisalābad, Punjab Province, Pakistan
View Trial Details